SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-19-000217
Filing Date
2019-01-07
Accepted
2019-01-07 08:02:53
Documents
80

Document Format Files

Seq Description Document Type Size
1 forms-1.htm S-1 1688000
2 ex5-1.htm EX-5.1 10154
3 logo_001.jpg GRAPHIC 8176
4 image_002.jpg GRAPHIC 25509
5 image_003.jpg GRAPHIC 33812
6 ex23-1.htm EX-23.1 3399
  Complete submission text file 0001493152-19-000217.txt   7046969

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE endv-20180930.xml EX-101.INS 1168782
8 XBRL SCHEMA FILE endv-20180930.xsd EX-101.SCH 71230
9 XBRL CALCULATION FILE endv-20180930_cal.xml EX-101.CAL 65980
10 XBRL DEFINITION FILE endv-20180930_def.xml EX-101.DEF 355911
11 XBRL LABEL FILE endv-20180930_lab.xml EX-101.LAB 476403
12 XBRL PRESENTATION FILE endv-20180930_pre.xml EX-101.PRE 442166
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-229146 | Film No.: 19512225
SIC: 2834 Pharmaceutical Preparations